PointState Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-130,000
Closed -$10.6M 125
2021
Q4
$10.6M Buy
130,000
+30,000
+30% +$2.19M 0.18% 59
2021
Q3
$6.64M Buy
100,000
+25,000
+33% +$1.77M 0.11% 97
2021
Q2
$5.02M Buy
+75,000
New +$4.65M 0.09% 96
2021
Q1
Sell
-40,494
Closed -$1.62M 166
2020
Q4
$1.62M Buy
40,494
+10,094
+33% +$326K 0.03% 115
2020
Q3
$745K Buy
+30,400
New +$777K 0.02% 98
2020
Q1
Sell
-28,800
Closed -$1.09M 110
2019
Q4
$1.09M Buy
+28,800
New +$863K 0.02% 93
2019
Q3
Sell
-36,200
Closed -$748K 140
2019
Q2
$748K Buy
+36,200
New +$834K 0.02% 103

Other funds holding THC

PointState Capital's THC Position: Q1 2022 in Review

PointState Capital sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 130,000 shares — an estimated $10.6M sold.

PointState Capital first reported a position in THC in Q2 2019 and held it in 7 quarters. The position peaked at $10.6M in Q4 2021. 404 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • PointState Capital reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
  • PointState Capital sold 130,000 Tenet Healthcare shares in Q1 2022, an estimated $10.6M.
  • PointState Capital first reported a position in Tenet Healthcare in Q2 2019 and held it in 7 quarters.
  • PointState Capital's Tenet Healthcare position peaked at $10.6M in Q4 2021.
  • 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.